Literature DB >> 22950912

Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer's disease.

Carlo Cervellati1, Eleonora Cremonini, Cristina Bosi, Stefania Magon, Amedeo Zurlo, Carlo M Bergamini, Giovanni Zuliani.   

Abstract

A large body of evidences obtained in human and animal brain tissue suggest a role of oxidative stress (OxS) in the pathogenesis of late onset Alzheimer's disease (LOAD); on the contrary, data on peripheral markers of OxS in LOAD are still controversial. We evaluated the serum levels of products of lipid peroxidation, hydroperoxides, advanced oxidation protein products, total and residual antioxidant power, thiols, and uric acid in a sample of 334 older individuals: 101 LOAD patients, 134 patients with mild cognitive impairment (MCI), and 99 controls. At univariate analysis, serum hydroperoxides were higher while residual antioxidant power was lower in MCI and LOAD compared with in controls. By multivariate logistic regression analysis we found that, compared with controls, high levels (over median value) of serum hydroperoxides were independently associated with an increase in the likehood of having MCI (Odd Ratio: 2.59, 95% Confidence Interval: 1.08-6.21) or LOAD (OR: 4.09, 95%CI: 1.36-11.81). Furthermore, low levels of residual antioxidant power (below the median value) were associated with increased risk of having MCI (OR: 3.97, 95% CI: 1.62-9.72), but not dementia (OR: 2.31, 95%CI: 0.83-6.63). Our study suggests that a systemic redox-imbalance leading to OxS might be associated not only with LOAD but also with MCI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22950912     DOI: 10.2174/1567205011310040003

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  28 in total

1.  The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial.

Authors:  A M Alavi Naeini; I Elmadfa; A Djazayery; M Barekatain; M R Aghaye Ghazvini; M Djalali; A Feizi
Journal:  Eur J Nutr       Date:  2013-12-11       Impact factor: 5.614

Review 2.  Mechanisms underlying the effect of acupuncture on cognitive improvement: a systematic review of animal studies.

Authors:  Mason Chin Pang Leung; Ka Keung Yip; Yuen Shan Ho; Flora Ka Wai Siu; Wai Chin Li; Belinda Garner
Journal:  J Neuroimmune Pharmacol       Date:  2014-06-06       Impact factor: 4.147

3.  Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis.

Authors:  Giacomo Lazzarino; Angela M Amorini; Axel Petzold; Claudio Gasperini; Serena Ruggieri; Maria Esmeralda Quartuccio; Giuseppe Lazzarino; Enrico Di Stasio; Barbara Tavazzi
Journal:  Mol Neurobiol       Date:  2016-11-08       Impact factor: 5.590

Review 4.  N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.

Authors:  Stephen D Skaper; Laura Facci; Massimo Barbierato; Morena Zusso; Giuseppe Bruschetta; Daniela Impellizzeri; Salvatore Cuzzocrea; Pietro Giusti
Journal:  Mol Neurobiol       Date:  2015-06-09       Impact factor: 5.590

Review 5.  Inverse Association Between Serum Uric Acid Levels and Alzheimer's Disease Risk.

Authors:  Na Du; Donghua Xu; Xu Hou; Xuejia Song; Cancan Liu; Ying Chen; Yangang Wang; Xin Li
Journal:  Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.590

6.  Zinc and the aging brain.

Authors:  Johnathan R Nuttall; Patricia I Oteiza
Journal:  Genes Nutr       Date:  2013-12-24       Impact factor: 5.523

Review 7.  Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

Authors:  Carlo Cervellati; Giuseppe Valacchi; Veronica Tisato; Giovanni Zuliani; Judit Marsillach
Journal:  Minerva Med       Date:  2018-10-11       Impact factor: 4.806

Review 8.  Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis.

Authors:  Aamir A Khan; Terence J Quinn; Jonathan Hewitt; Yuhua Fan; Jesse Dawson
Journal:  Age (Dordr)       Date:  2016-01-28

9.  Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer's disease.

Authors:  Carlo Cervellati; Alessandro Trentini; Valentina Rosta; Angelina Passaro; Cristina Bosi; Juana Maria Sanz; Stefania Bonazzi; Salvatore Pacifico; Davide Seripa; Giuseppe Valacchi; Remo Guerini; Giovanni Zuliani
Journal:  Geroscience       Date:  2019-11-19       Impact factor: 7.713

10.  Hydrogen Sulfide Ameliorates Lipopolysaccharide-Induced Memory Impairment in Mice by Reducing Apoptosis, Oxidative, and Inflammatory Effects.

Authors:  Viplav Kshirsagar; Chetan Thingore; Malvika Gursahani; Nitin Gawali; Archana Juvekar
Journal:  Neurotox Res       Date:  2021-05-22       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.